Publication | Closed Access

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study

Long-acting OctreotideHepatologyMedicinePathologyPlacebo-controlled StudyLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma